Search for: "Endo Generics Holding, Inc"
Results 21 - 40
of 56
Sorted by Relevance
|
Sort by Date
12 Oct 2010, 8:56 pm
General Media goof up over India-EU ‘settlement’ (Spicy IP) (Spicy IP) (Generic Pharmaceuticals and IP) Burdened with brackets, biodiversity ABS protocol needs political will to survive (IP Watch) Brazil: Deposit of microorganism for patents applications (IP tango) India: Student groups ask for reconsideration of TRIPS-plus provisions of EU-India FTA (Spicy IP) India: DIPP receives diverse replies to its compulsory licensing policy discussion paper (Spicy IP) India: An… [read post]
1 Jul 2014, 6:16 am
Symptoms of low-T include: Loss of libido Decreased muscle mass Fatigue Products affected by the FDA request include AbbVie Inc’s AndroGel, Endo International Plc’s Aveed and Trimel Pharmaceuticals Corp’s Natesto. [read post]
1 Apr 2010, 8:07 am
See Ethicon Endo-Surgery, Inc. v. [read post]
7 Jan 2022, 12:56 pm
In September, Endo agreed to pay at least $50 million. [read post]
7 Jan 2022, 12:56 pm
In September, Endo agreed to pay at least $50 million. [read post]
18 May 2016, 8:19 am
Supplying Components Abroad: The Solicitor General has finally filed its brief in Life Tech v. [read post]
10 Jul 2008, 5:31 pm
Nov. 6, 2000 & July 9, 2001).Texas: Ethicon Endo-Surgery, Inc. v. [read post]
30 Jul 2021, 7:01 am
The New York State opioid trial continues against three major drugmakers, Endo International Plc., Teva Pharmaceutical Industries Ltd., and AbbVie Inc’s Allergan unit, which all stand accused of having deceptively marketed their opioid painkillers. [read post]
5 Mar 2010, 9:10 pm
Ethicon Endo-Surgery, Inc. v. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
28 Sep 2016, 8:39 am
Momenta Pharmaceuticals, Inc., et al., No. 15-1402 (scope of 271(e) safe harbor) Post Grant Admin: Ethicon Endo-Surgery, Inc. v. [read post]
21 Dec 2009, 5:24 am
Ethicon Endo-Surgery (Property, intangible) CAFC: The presumption of irreparable harm? [read post]
24 Aug 2011, 12:33 am
The lobbying push for a PTE (FDA Law Blog) US: Generics fees: A fantastic opportunity (profitability through simplicity) USPTO announces agenda for next BCP customer partnership meeting (Patent Docs) US: GOP candidates unified in opposition to embryonic cell research (Patent Docs) US: District Court Massachusetts: Method of detecting fetal down syndrome passes muster under Bilski‘s machine-or-transformation test: PerkinElmer, Inc., et. al. v. [read post]
16 Jan 2017, 5:44 pm
Post Grant Admin: Ethicon Endo-Surgery, Inc. v. [read post]
14 Nov 2016, 9:16 am
Apple) ITC Jurisdiction: DBN Holding, Inc. [read post]
13 Oct 2016, 6:50 am
Apple) ITC Jurisdiction: DBN Holding, Inc. [read post]
3 Jun 2016, 6:40 am
§ 271(e)(1) and asks: Whether the safe harbor protects a generic drug manufacturer’s bioequivalence testing that is performed only as a condition of maintaining FDA approval and is documented in records that must be submitted to the FDA upon request. [read post]
5 May 2010, 10:14 pm
Case law on any issue generally offering the opportunity to throw mud pies in both directions, the CAFC majority opinion admits "some divergence. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram)… [read post]
30 Sep 2011, 8:05 am
Fellow mesh makers, including Johnson & Johnson (NYSE:JNJ) and Endo Pharmaceuticals Holdings Inc. [read post]
